PMID- 28810595 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 1792-0981 (Print) IS - 1792-1015 (Electronic) IS - 1792-0981 (Linking) VI - 14 IP - 2 DP - 2017 Aug TI - SUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes. PG - 1343-1350 LID - 10.3892/etm.2017.4689 [doi] AB - SUDOSCAN is a non-invasive method of measuring peripheral small fiber and autonomic nerve activity by detection of abnormal sweat gland function through electrochemical skin conductance. It has been reported to be an effective screening tool in early detection of microvascular type 2 diabetes mellitus (T2DM) complications including diabetic neuropathy and nephropathy in recent studies. However, previous studies used estimated glomerular filtration rate (eGFR) as the golden standard, which has a 90% chance of being within 30% of the measured GFR at best. No relevant study has been performed in the Chinese population concerning SUDOSCAN in the screening of diabetic nephropathy (DN) in comparison with GFR. In this cross-sectional study, SUDOSCAN was performed in 176 Chinese patients with T2DM between September 2014 and September 2015. It was found that the SUDOSCAN test had a sensitivity of 57.8% and a specificity of 100% to detect chronic kidney disease at a cut-off SUDOSCAN-DN score of 59.5. The area under receiver operating characteristic curve for DN was 0.85 [95% confidence interval (CI), 0.76-0.93] compared with 0.84 for eGFR(MDRD) (MDRD, modification of diet in renal disease; 95% CI, 0.71-0.98) and 0.77 for eGFR(EPI) (EPI, epidemiology collaboration; 95% CI, 0.68-0.87). Patients with DN score <59.5 had a significantly lower GFR level (P<0.001) and significantly older age (P<0.001), longer duration of T2DM (P<0.001) and higher risk of diabetic complications, including diabetic neuropathy (P<0.001) and peripheral vascular disease (P<0.05). These results suggested that SUDOSCAN may be useful for detecting patients at risk of impaired renal function as part of a screening program in the Chinese population with T2DM. FAU - Mao, Fei AU - Mao F AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Liu, Siying AU - Liu S AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Qiao, Xiaona AU - Qiao X AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Zheng, Hangping AU - Zheng H AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Xiong, Qian AU - Xiong Q AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. AD - Department of Endocrinology and Metabolism, Jing'an Center Hospital of Shanghai, Shanghai 200040, P.R. China. FAU - Wen, Jie AU - Wen J AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. AD - Department of Endocrinology and Metabolism, Jing'an Center Hospital of Shanghai, Shanghai 200040, P.R. China. FAU - Zhang, Shuo AU - Zhang S AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Zhang, Zhaoyun AU - Zhang Z AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Ye, Hongying AU - Ye H AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Shi, Hongli AU - Shi H AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Lu, Bin AU - Lu B AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. FAU - Li, Yiming AU - Li Y AD - Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. AD - Department of Endocrinology and Metabolism, Jing'an Center Hospital of Shanghai, Shanghai 200040, P.R. China. LA - eng PT - Journal Article DEP - 20170627 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC5525651 OTO - NOTNLM OT - SUDOSCAN OT - diabetic nephropathy OT - modification of diet in renal disease OT - screening OT - type 2 diabetes mellitus EDAT- 2017/08/16 06:00 MHDA- 2017/08/16 06:01 PMCR- 2017/06/27 CRDT- 2017/08/17 06:00 PHST- 2016/05/09 00:00 [received] PHST- 2017/03/23 00:00 [accepted] PHST- 2017/08/17 06:00 [entrez] PHST- 2017/08/16 06:00 [pubmed] PHST- 2017/08/16 06:01 [medline] PHST- 2017/06/27 00:00 [pmc-release] AID - ETM-0-0-4689 [pii] AID - 10.3892/etm.2017.4689 [doi] PST - ppublish SO - Exp Ther Med. 2017 Aug;14(2):1343-1350. doi: 10.3892/etm.2017.4689. Epub 2017 Jun 27.